Global Acute Respiratory Distress Syndrome (ARDS) Market is Expected to Grow at 10.1% in the Forecast Period of 2022 to 2029

Global Acute Respiratory Distress Syndrome (ARDS) Market is growing due to increasing prevalence and acute lung injury diseases are driving the growth of the market. Increasing COVID-19 infection which is associated with ARDS is also propelling the growth of the global ARDS market. However, the high cost of treatment may hamper the growth of the market.

Global Acute Respiratory Distress Syndrome (ARDS) Market Scenario

According to Data Bridge Market Research, the market for global acute respiratory distress syndrome (ARDS) market in Asia-Pacific region has the highest market share in the global acute respiratory distress syndrome (ARDS) market. Market leader is Gilead Sciences, Inc., which account an estimated market share of approximately 60% to 70%. The company has gained outstanding sale through providing healthcare devices and different medicines.

• In July 2020, Gilead Sciences Inc. initiated clinical testing of an inhaled solution of Remdesivir for potential outpatient treatment of COVID-19. This testing helped the company enhance its antiviral product portfolio, thereby strengthening its footprints over the market.

Trends Impacting the Market

Now the question is which other regions Gilead Sciences, Inc., Terumo Medical Corporation, Getinge AB., LivaNova PLC, and Medtronic are targeting? Data Bridge Market Research has estimated a large growth in North America acute respiratory distress syndrome (ARDS) market and the market leaders targeting U.S., Canada and Mexico to be their next revenue pockets for 2021.

The global acute respiratory distress syndrome (ARDS) market is becoming more competitive with companies such as Gilead Sciences, Inc., Terumo Medical Corporation, Getinge AB., LivaNova PLC, and Medtronic as they are the top dominating companies in acute respiratory distress syndrome (ARDS) market having maximum number of products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global acute respiratory distress syndrome (ARDS) market.   

For more analysis on the global acute respiratory distress syndrome (ARDS) market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-acute-respiratory-distress-syndrome-ards-market

Global Acute Respiratory Distress Syndrome (ARDS) Market Development

• In July 2020, Gilead Sciences Inc. initiated clinical testing of an inhaled solution of Remdesivir for potential outpatient treatment of COVID-19. This testing helped the company enhance its antiviral product portfolio, thereby strengthening its footprints over the market.

Scope of the Global Acute Respiratory Distress Syndrome (ARDS) Market

Global acute respiratory distress syndrome (ARDS) market is segmented on the basis of countries into North America, Europe, Asia-Pacific, South America and Middle East and Africa. These regions are further segmented into major countries such as the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Turkey, Hungary, Netherlands, Switzerland, Austria Lithuania, Poland, Russia, Ireland, Norway, Rest of Europe, Japan, China, South Korea ,India Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of  Asia-Pacific, South Africa, Saudi Arabia, U.A.E, Israel, Egypt, Kuwait, Rest of Middle East and Africa, Brazil , Argentina, Peru, Rest of South America.

• On the basis of cause, the global acute respiratory distress syndrome (ARDS) market is segmented into coronavirus disease 2019 (COVID-19), sepsis, inhalation of harmful substances, severe pneumonia and others. On the basis of type, the global acute respiratory distress syndrome (ARDS) market is segmented into diagnosis and treatment. On the basis of route of administration, the global acute respiratory distress syndrome (ARDS) market is segmented into oral, parenteral and others. The parenteral segment is further segmented into intramuscular and intravenous. On the basis of end-users, the global acute respiratory distress syndrome (ARDS) market is segmented into hospitals, specialty clinics, home healthcare and others. On the basis of distribution channel, the global acute respiratory distress syndrome (ARDS) market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.

Key Pointers Covered in Global Acute Respiratory Distress Syndrome (ARDS) Market Industry Trends and Forecast to 2029

• Market Size
• Top to Bottom Market Analysis
• Recent Developments for Market Competitors
• Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

The key market players for global acute respiratory distress syndrome (ARDS) market are listed below:

• Gilead Sciences, Inc. 
• Terumo Medical Corporation
• Getinge AB.
• LivaNova PLC
• Medtronic
• ResMed
• Fisher & Paykel Healthcare Limited.
• F. Hoffmann-La Roche Ltd
• Smiths Medical (part of ICU Medical, Inc.)
• Drägerwerk AG & Co. KGaA
• NIPRO 
• Fresenius SE & Co. KGaA
• Hamilton Medical
• Pfizer Inc.
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• EUROSETS
• Armstrong Medical
• nice Neotech Medical Systems Pvt. Ltd.
• Besmed Health Business Corp.
• ALung Technologies, Inc.

Above are the key players covered in the report, to know about more and exhaustive list of global acute respiratory distress syndrome (ARDS) market companies, contact us  https://www.databridgemarketresearch.com/reports/global-acute-respiratory-distress-syndrome-ards-market

Research Methodology: Global Acute Respiratory Distress Syndrome (ARDS) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

• Demand Side: Clinicians, Healthcare Professionals, Researchers, Academician.

• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

• Global Respiratory Care Devices Market - Industry Trends and Forecast to 2027
• Global Middle East Respiratory Syndrome (MERS) Market - Industry Trends and Forecast to 2027

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/